Holdings
40
Concentrated
Top 10 weight
47%
Concentration
Strategy data
N/A
Not reported
Equity
81%
Asset allocation
Portfolio
16Sectors
2Large positions
12.4%Top: Pharmaceuticals & Biotechnology
0.0%Cash
Market-cap allocation
Large cap38%
Mid cap20%
Small cap19%
Asset allocation
Equity81%
Debt10%
Top holdings
TrepsDERIVATIVE
9.8%9.6%
5.0%
ICICI Bank Ltd.EQUITY
3.6%Cummins India Ltd.EQUITY
3.5%Mahindra & Mahindra Ltd.EQUITY
3.4%TVS Motor Company Ltd.EQUITY
3.4%Persistent Systems Ltd.EQUITY
3.1%Titan Company Ltd.EQUITY
3.0%3.0%
Radico Khaitan Ltd.EQUITY
2.7%2.7%
Coforge Ltd.EQUITY
2.7%Ajanta Pharma Ltd.EQUITY
2.6%2.6%
2.5%
Eternal Ltd.EQUITY
2.5%Larsen & Toubro Ltd.EQUITY
2.5%The Federal Bank Ltd.EQUITY
2.5%Shriram Finance Ltd.EQUITY
2.4%2.3%
2.1%
2.0%
Axis Bank Ltd.EQUITY
2.0%Apar Industries Ltd.EQUITY
1.7%KSH International Ltd.EQUITY
1.5%Avalon Technologies Ltd.EQUITY
1.5%1.5%
1.4%
1.4%
1.4%
Mphasis Ltd.EQUITY
1.3%InterGlobe Aviation Ltd.EQUITY
1.3%Alkem Laboratories Ltd.EQUITY
1.2%K.P.R. Mill Ltd.EQUITY
1.1%Metro Brands Ltd.EQUITY
0.96%0.92%
0.90%
BSE Ltd.EQUITY
0.89%Net Receivables / (Payables)DERIVATIVE
-0.2%AI Smart summary
Portfolio read
- 81% equity, 10% debt.
- 40 disclosed positions across 16 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 12.4% of the portfolio.
Watchpoints
- No threshold-based concentration or allocation warning was triggered by the available portfolio data.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Comparable funds require category or compatible portfolio metadata. Explore comparable funds →
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
12.4%
11.0%
7.4%
7.1%
6.8%
6.5%
4.9%
4.9%
3.4%
2.9%
2.7%
2.7%
2.5%
2.5%
Other 2 sectors3.1%
2.1%
1.1%